Saturday, 31 October 2026European Markets
ExploreSearch
ViaNews EU
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· December 9, 2025

Carrefour, Carmila, Unlimitail and JCDecaux join forces to accelerate the development of retail media across Carrefour and Carmila sites in France and Spain

View original at globenewswire.com
Carrefour, Carmila, Unlimitail and JCDecaux join forces to accelerate the development of retail media across Carrefour and Carmila sites in France and Spain Carrefour, Carmila, Unlimitail and JCDecaux join forces to accelerate the development of retail media across Carrefour and Carmila sites in France and Spain Paris,…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • This project confirms our retail media expertise and leadership. Physical and digital inventory and data can be fully monetised when they are combined for the benefit of retailers, brands and shoppers throughout the customer journey.

    80% confidence

  • We are delighted to partner with Carrefour, Carmila and Unlimitail on this project, which further strengthens our partnerships in France and Spain. Physical retail media has been enjoying strong growth for several years and this partnership is fully in line with that momentum. Together, we will make it a powerful lever supporting advertisers' omnichannel strategies. By combining our DOOH solutions with Carrefour's transactional data and Unlimitail's technological expertise, we will offer brands even greater visibility, proximity and effectiveness.

    80% confidence

  • With this new retail media network, Carmila is taking a key step in the transformation of its shopping centre portfolio. We are creating new opportunities to monetise our audiences and accelerate the growth of our revenues, while further enhancing the attractiveness of our sites.

    80% confidence

  • Our sites are undergoing a profound transformation, and this project is a powerful symbol of that change. It reflects our ambition to combine innovation and service in order to offer visitors a renewed, modern and welcoming experience, while creating long-term value for our assets.

    80% confidence

  • This agreement will make retail media an even more powerful growth driver for retail partners and brands

    80% confidence

  • This project will be the largest multi-site deployment ever undertaken by JCDecaux in France

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com